The United States Indocyanine Green Sales Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Indocyanine Green Sales Market By Application
- Ophthalmology
- Neurosurgery
- Cardiovascular
- Cancer Diagnosis
- Organ Transplant
The market for Indocyanine Green (ICG) in the United States is segmented by application into several key areas. In ophthalmology, ICG is primarily used for angiography to assess blood flow in the retina and choroid, aiding in the diagnosis of various eye conditions. In neurosurgery, ICG finds application in intraoperative imaging to assist surgeons in identifying blood flow and distinguishing tumors from healthy tissue, enhancing precision during operations.
Furthermore, in cardiovascular procedures, ICG is utilized to evaluate cardiac output and hepatic function, crucial for managing patients with heart conditions. In cancer diagnosis, particularly in identifying liver tumors and evaluating lymphatic mapping, ICG plays a pivotal role due to its fluorescent properties. Lastly, in organ transplant surgeries, ICG helps in assessing tissue perfusion and organ viability, ensuring better outcomes for transplant recipients.